Novel combinational therapies:Is the increased toxicity worth the possibility of increased benefit?
Kidney Cancer
The speaker begins by highlighting the significant evolution in treating metastatic kidney cancer, noting a shift from sequential single-agent therapies before 2015 to more complex combination strategies. Historically, treatments were administered one after another as patients progressed on a drug u …